Marker Therapeutics Stock Forecast - Variance
Marker Stock Forecast is based on your current time horizon.
Marker |
| Check Marker Therapeutics Volatility | Backtest Marker Therapeutics | Information Ratio |
View Marker Therapeutics Related Equities
| Risk & Return | Correlation |
Marker Therapeutics Risk Indicators
The analysis of Marker Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Marker Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting marker stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.35 | |||
| Standard Deviation | 7.54 | |||
| Variance | 56.84 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Marker Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Marker Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Marker Stock
| 0.63 | ENVB | Enveric Biosciences Earnings Call This Week | PairCorr |
Moving against Marker Stock
| 0.73 | VIGL | Vigil Neuroscience | PairCorr |
| 0.65 | ETON | Eton Pharmaceuticals | PairCorr |
| 0.65 | LLY | Eli Lilly | PairCorr |
| 0.62 | IVA | Inventiva Sa | PairCorr |
| 0.55 | PBH | Prestige Brand Holdings | PairCorr |
The ability to find closely correlated positions to Autodesk could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Autodesk when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Autodesk - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Autodesk to buy it.
The correlation of Autodesk is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Autodesk moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Autodesk moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Autodesk can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Marker Stock Analysis
When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.